Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
about
Gene Therapy for Pediatric Cancer: State of the Art and Future PerspectivesMouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.Prevention and treatment of viral infections in stem cell transplant recipients.Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management.Cellular immunotherapy for viral infection after HSC transplantation.Adenovirus as an emerging pathogen in immunocompromised patients.Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity.Management of respiratory viral infections in hematopoietic cell transplant recipients.The challenge of respiratory virus infections in hematopoietic cell transplant recipients.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation.Cyclic recovery of adenovirus in a stem cell transplant recipient: an inverse association with graft-versus-host disease.
P2860
Q24792778-AEE395F8-AAAA-4AF1-AA69-1BF1A8247A03Q34123729-A89E45C3-6EA0-4DD9-BA2D-8F66EDF1AFE8Q34722706-3F46EB22-3B59-4BE1-A05E-051B71DB445CQ35854783-DA1CCB12-AF44-4C19-A692-5E8773976ABBQ35998792-3B955BE2-4A2E-43F7-9379-43A4D39CCB80Q36003090-ED8ACA40-42A3-4ADE-A188-409B5164E20BQ36090231-2C3924F1-C256-4D7A-9330-F8AC9A732CEFQ36439896-2D9D03A9-6BED-4430-88B7-C95B5D49D4C5Q37266577-288DB362-C818-4C8D-A6D1-94E95A2ACD8FQ37426542-E297A651-606F-493B-BCCF-3A7422028540Q40051360-257EBC42-66CD-4C43-AF26-BE78CF53F70FQ46648242-6967284F-EB3D-42F0-AFD5-EF3F1BC8433BQ54785711-9EF12624-DABF-4031-95B5-D43A02AA1488
P2860
Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Ex vivo generation of cytotoxi ...... geneic bone marrow transplant.
@en
Ex vivo generation of cytotoxi ...... geneic bone marrow transplant.
@nl
type
label
Ex vivo generation of cytotoxi ...... geneic bone marrow transplant.
@en
Ex vivo generation of cytotoxi ...... geneic bone marrow transplant.
@nl
prefLabel
Ex vivo generation of cytotoxi ...... geneic bone marrow transplant.
@en
Ex vivo generation of cytotoxi ...... geneic bone marrow transplant.
@nl
P2093
P2860
P356
P1476
Ex vivo generation of cytotoxi ...... geneic bone marrow transplant.
@en
P2093
P2860
P2888
P356
10.1038/SJ.BMT.1702752
P407
P577
2001-01-01T00:00:00Z